Enosis Therapeutics Generates Positive Results from World’s First Study of the Synergistic Application of Virtual Reality and Psychedelics

Enosis Therapeutics has announced the successful completion of the world’s first study on the synergistic application of VR and psychedelics. The study, led by researchers and co-founders of Enosis Therapeutics, Agnieszka Sekula and Prash Puspanathan, was conducted in the Netherlands and in collaboration with Swinburne University of Technology and the Psychedelic Society Belgium.

Category Press Release
Published in Biospace